As experience of the most effective way to use cyclosporine for immunosuppression in organ transplantation grows, new drugs are emerging, which may improve the potency of future immunosuppressive protocols or at least provide alternative drugs in selected situations. These newer agents include FK506
Comparison of FK-506 and cyclosporine regimens in pediatric renal transplantation
β Scribed by Demetrius Ellis; Ron Shapiro; Mark L. Jordan; Velma P. Scantlebury; Nisan Gilboa; Laszlo Hopp; Nancy Weichler; Andreas G. Tzakis; Richard L. Simmons
- Publisher
- Springer
- Year
- 1994
- Tongue
- English
- Weight
- 967 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0931-041X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Hypertension frequently develops early after liver transplantation when cyclosporine-based immunosuppression is used. However, initial experience with tacrolimus has suggested that its use leads to a lower early incidence of hypertension. In this study, the blood pressure status of patients treated
The development of atherosclerotic cardiovascular complications is a common and serious problem for the long-term survivors of organ transplantation. Cyclosporine A plus steroid-based immuno-suppression regimens in these patients are associated with the development of hypertension, hyperlipidemia, o